About the Immuno-Oncology Summit

Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs. Learn more.

Conference Programs

AUGUST 27-28, 2018

AUGUST 28-29, 2018

AUGUST 30-31, 2018

Immunomodulatory Antibodies

 

Bispecific Antibodies

 

Immuno-Oncology Targets

 

Combination Immunotherapy

 

Preclinical & Translational IO

 

Personalized Cancer Vaccines

 

IO Biomarkers 1: Immune Profiling and Immune Monitoring

 

IO Biomarkers 2: Predictive Biomarkers and Companion Diagnostics

 

Neoantigen Targeted Therapies

 

Oncolytic Virus Immunotherapy

 

Adoptive T Cell Therapy 1: Discovery

 

Adoptive T Cell Therapy 2: Development

 

Training Seminar 1: CAR-T Engineering for Protein Scientists

 

Training Seminar 2: Immunology for Drug Discovery Scientists

 

Immuno-Oncology Investing & Partnering Forum

 

 

 

Plenary Keynotes

CAR-T Therapy for B Cell Malignancies

Jennifer Brogdon, PhD, Director, Exploratory Immuno-Oncology, Novartis

Walking on the Moon: Reflections on the Work of the Cancer Moonshot and the Future of the Biden Cancer Initiative

Gregory C. Simon, JD, President, Biden Cancer Initiative

Short Courses

• Bioinformatics for Immuno-Oncology and Translational Research
• Next-Generation Immunotherapies: Part 1
• Next-Generation Immunotherapies: Part 2